Low levels of IgM antibodies against phosphorylcholine predict development of coronary artery disease in a population based cohort

被引：0
|
作者：
Frostegard, J. [1 ]
Gronlund, H. [1 ]
Hallmans, G. [2 ]
Jansson, J. H. [2 ]
Boman, K. [2 ]
Wikstrom, M. [1 ]
Dahlbom, I. [3 ]
Lettesjo, H. [4 ]
De Faire, U. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Umea Univ, Umea, Sweden
[3] Uppsala Univ, Uppsala, Sweden
[4] Athera Biotechnol AB, Stockholm, Sweden
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：774 / 774
页数：1
相关论文
共 50 条
  • [21] Low levels of IgM antibodies against phosphorylcholine (anti-pc) are related to abdominal obesity and impaired fibrinolysis in the elderly
    Pettersson, K.
    Siegbahn, A.
    Lettesjo, H.
    Dahlbom, I.
    Frostegard, J.
    Lind, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 709 - 709
  • [22] Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease?
    Eryol, NK
    Kiliç, M
    Gül, A
    Özdrogru, I
    Inanç, T
    Dogan, A
    Topsakal, R
    Basar, E
    INTERNATIONAL HEART JOURNAL, 2005, 46 (02) : 205 - 209
  • [23] Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: Effects on uptake of oxidized LDL in macrophages as a potential mechanism
    de Faire, Ulf
    Su, Jun
    Hua, Xiang
    Frostegard, Anna
    Halldin, Mats
    Hellenius, Mai-Lis
    Wikstrom, Max
    Dahlbom, Ingrid
    Gronlund, Hans
    Frostegard, Johan
    JOURNAL OF AUTOIMMUNITY, 2010, 34 (02) : 73 - 79
  • [24] RANTES levels predict angiographic coronary artery disease but not mortality in an angiography population
    DiPalma, Stefanie
    Frohlich, Jiri J.
    Hill, John S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E122 - E122
  • [25] Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus
    Cristina Anania
    Thomas Gustafsson
    Xiang Hua
    Jun Su
    Max Vikström
    Ulf de Faire
    Mikael Heimbürger
    Tomas Jogestrand
    Johan Frostegård
    Arthritis Research & Therapy, 12
  • [26] Low levels of IgM antibodies against phosphorylcholine are not associated with glucometabolic disturbances in patients with acute ST-elevation myocardial infarction
    Knudsen, E. C.
    Seljeflot, I.
    Muller, C.
    Andersen, G. O.
    EUROPEAN HEART JOURNAL, 2012, 33 : 887 - 888
  • [27] Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men
    Gigante, Bruna
    Leander, Karin
    Vikstrom, Max
    Baldassarre, Damiano
    Veglia, Fabrizio
    Strawbridge, Rona J.
    McLeod, Olga
    Gertow, Karl
    Sennblad, Bengt
    Shah, Sonia
    Zabaneh, Delilah
    Humphries, Steve E.
    Kauhanen, Jussi p
    Rauramaa, Rainer
    Smit, Andries J.
    Mannarino, Elmo
    Giral, Philippe
    Tremoli, Elena
    Hamsten, Anders
    Frostegard, Johan
    De Faire, Ulf
    ATHEROSCLEROSIS, 2014, 236 (02) : 394 - 399
  • [28] Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus
    Anania, Cristina
    Gustafsson, Thomas
    Hua, Xiang
    Su, Jun
    Vikstrom, Max
    de Faire, Ulf
    Heimburger, Mikael
    Jogestrand, Tomas
    Frostegard, Johan
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (06)
  • [29] Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion
    Padilla, ND
    Ciurana, C
    van Oers, J
    Ogilvie, AC
    Hack, CE
    JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 293 (1-2) : 1 - 11
  • [30] Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease
    Imhof, Armin
    Koenig, Wolfgang
    Jaensch, Andrea
    Mons, Ute
    Brenner, Hermann
    Rothenbacher, Dietrich
    ATHEROSCLEROSIS, 2015, 243 (02) : 414 - 420
12345